This contract expires in 112 days (Sep 30, 2026).
WERFEN USA LLC - BLOOD BANK REAGENTS
Key Details
Description
BLOOD BANK REAGENTS
Context & Analysis
On Oct 29, 2025, Department of Defense obligated $23,829.18 to WERFEN USA LLC for blood bank reagents. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in JACKSONVILLE, FL. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Defense under NAICS 325413 — related awards are listed below.
Contractor Information
Similar Awards
NUCLEIC ACID ACTIVE REAGENTS AND ASSAY KITS FOR PANTHER AND FUSION INSTRUMENTS FOR TAMC 03/01/2022-09/30/2026
HOLOGIC SALES AND SERVICE, LLC
$2.0M
VARIOUS REAGENTS FOR GENEXPERT INFINITY SYSTEM MOLECULAR ANALYZER AND RENTAL/SERVICE OF ANALYZER. BASE PERIOD: 1 OCT 2021 - 30 SEP 2022
CEPHEID
$2.0M
FY25 SAF IMMUNO-ANALYZERS MICROBIOLOGY
FISHER SCIENTIFIC COMPANY L.L.C.
$1.6M
EQUIPMENT AND SUPPLIES FOR THE TOTAL LABORATORY AUTOMATION SYSTEM INCLUDING CLINICAL CHEMISTRY, IMMUNOCHEMISTRY, HEMATOLOGY, COAGULATION, AND SEROLOGY AT THE LANDSTUHL REGIONAL MEDICAL CENTER, GERMANY.
BECKMAN COULTER GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
$1.6M
FOR MOLECULAR TRANSPLANT, RESPIRATORY, AND SEXUAL HEALTH TESTING DEPARTMENT OF PATHOLOGY AND AREA LABORATORY SERVICES
ABBOTT MOLECULAR INC.
$1.5M
Stay Updated
Get notified about new opportunities matching your interests.